Synopsis

The purpose of the talk is to describe the newly developed VI-RADS scoring system aimed at standardization of MRI acquisition, interpretation, and reporting for urinary bladder cancer (BCa). An insight will be given on the BCa diagnostic issues, MRI applications for BCa local staging with assessment of muscle invasiveness, and clinical implications of the score for the disease management. In addition, future prospective of the score applicability will be provided, on its role in patients’ stratification for therapeutic planning, disease surveillance, and for the evaluation of response to therapy. Finally, a clinical series with multiple-choice questions will be shown.